Cell Therapies: New Frontier for the Management of Diabetic Foot Ulceration
- 31 May 2024
- book chapter
- Published by Springer Nature
- p. 253-271
Abstract
No abstract availableKeywords
This publication has 197 references indexed in Scilit:
- Optimization of extracellular matrix production from human induced pluripotent stem cell‐derived fibroblasts for scaffold fabrication for application in wound healingJournal of Biomedical Materials Research Part A, 2021
- Scaffolds Functionalized with Matrix from Induced Pluripotent Stem Cell Fibroblasts for Diabetic Wound HealingAdvanced Healthcare Materials, 2020
- CD93 hematopoietic stem cells improve diabetic wound healing by VEGF activation and downregulation of DAPK‐1Journal of Cellular Physiology, 2019
- Characterization of human adipose tissue‐derived stromal cells isolated from diabetic patient's distal limbs with critical ischemiaCell Biochemistry and Function, 2014
- Both autologous bone marrow mononuclear cell and peripheral blood progenitor cell therapies similarly improve ischaemia in patients with diabetic foot in comparison with control treatmentDiabetes/Metabolism Research and Reviews, 2013
- Derivation of Mesenchymal Stem Cells from Human Induced Pluripotent Stem Cells Cultured on Synthetic SubstratesStem Cells, 2012
- A systematic review of interventions to enhance the healing of chronic ulcers of the foot in diabetesDiabetes/Metabolism Research and Reviews, 2012
- Treatment of Chronic Wounds With Bone Marrow–Derived CellsArchives of Dermatology, 2003
- High glucose-induced growth factor resistance in human fibroblasts can be reversed by antioxidants and protein kinase C-inhibitorsCell Biochemistry and Function, 1997
- Development of a bilayered living skin construct for clinical applicationsBiotechnology and Bioengineering, 1994